Insulin Detemir and Levemir and Xultophy — marketed mostly in the format of pre-filled disposable pen and cartridges (Penfill and FlexPen). The company recently informed its marketing partner ...

Novo Nordisk will continue offering its top-selling insulin brand, Mixtard, in vial form in India, despite phasing out Penfill cartridges. This decision follows concerns about the discontinuation ...

5,000 crore insulin market including Actrapid, Insulatard, Insulin Detemir, Levemir and Xultophy, which are marketed primarily in the format of pre-filled disposable pen and cartridges (Penfill and ...

With well-known medications, including Ozempic, Wegovy, and NovoRapid, the company is a world leader in insulin and GLP-1 therapy. With a 26% increase in sales and a 26% increase in operating ...

The new PenCycle programme covers Novo Nordisk's FlexPen and FlexTouch devices, which are used to dispense insulin and other medications. Users of the devices in the UK will shortly be able to ...

Novo Nordisk's insulin aspart franchise is a DKK 10.6 billion ($1.5 billion) business worldwide, with NovoLog (known as NovoRapid outside the US) making up the bulk (around DKK 9 billion ...

Types of insulin include rapid-, regular-, intermediate-, and long-acting, based on how long they take to start working. You may take a combination of these when managing type 2 diabetes. If you ...

which are marketed primarily in the format of pre-filled disposable pen and cartridges (Penfill and FlexPen). TOI accessed documents that said the company recently informed marketing partner, Abbott ...